Type | overall OR | High prevalence countries OR (95% CI) | Intermediate prevalence countries OR (95% CI) | Low prevalence countries OR (95% CI) |
---|---|---|---|---|
NHL | 2.09 (1.76–2.50) (*P < 0.01) n = 35 | 2.20 (1.78–2.72) (P < 0.01) n = 15 | 2.48 (1.55–3.95) (P < 0.01) n = 10 | 1.64 (1.15–2.34) (P < 0.01) n = 10 |
DLBCL | 2.15 (1.52–3.02) (P < 0.01) n = 14 | 2.69 (1.88–3.86) (P < 0.01) n = 6 | 3.38 (2.13–5.36) (P = 0.47) n = 3 | 1.14 (0.58–2.26) (P < 0.01) n = 5 |
BL | 2.22 (0.87–5.66) (P < 0.01) n = 7 | 1.50 (0.94–2.40) (P = 0.79) n = 6 | n = 0 | n = 1 |
CLL/SLL | 1.37 (0.93–2.00) (P < 0.01) n = 11 | 1.61 (1.00–2.58) (P = 0.09) n = 5 | n = 1 | 1.33 (0.66–2.67) (P = 0.02) n = 5 |
FL | 1.81 (1.12–2.94) (P < 0.01) n = 13 | 2.42 (1.36–4.32) (P < 0.01) n = 6 | 4.17 (2.06–8.46) (P = 0.71) n = 2 | 0.85 (0.44–1.66) (P = 0.02) n = 5 |
NK/T | 1.30 (0.82–2.08) (P = 0.06) n = 7 | 1.23 (0.76–1.89) (P = 0.04) n = 5 | 4.51(0.56–36.25) (P = 0.57) n = 2 | n = 0 |
PTCL | 1.31 (0.89–1.91) (P = 0.44) n = 4 | 1.31 (0.89–1.91) (P = 0.44) n = 4 | n = 0 | n = 0 |
ALCL | 3.23 (1.27–8.18) (P = 0.04) n = 3 | 3.23 (1.27–8.18) (P = 0.04) n = 3 | n = 0 | n = 0 |